Evaluation of Iron Supplementation During Darbepoetin Alfa Treatment in Prophylaxis of Severe Anaemia Chemo-Induced

NCT00210002 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Neoplasms
Anemia

Interventions

DRUG: Darbepoetin alfa (Aranesp®)
DRUG: Ferric saccharose(Venofer®)

Sponsor

Institut Claudius Regaud